Genmab A/S

Common Name

Genmab

Country

Denmark

Sector

Healthcare

Industry

Biotechnology

Employees

2,639

Ticker

GMAB

Exchange

NASDAQ COPENHAGEN A/S

Website

www.genmab.com

Description

Genmab A/S is an international biotechnology company focused on the research, development, and commercialization of innovative antibody-based therapies. Its primary mission is to transform the treatme... Show more

Financial Statements of Genmab

Below are the financial statements of Genmab, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in billions of DKK	2024	2023
Assets	—	—
Goodwill	2.54^a	0^a
Other intangible assets	12.34^a	0.1^a
Property and equipment	0.98^a	0.96^a
Right-of-use assets	0.91^a	0.69^a
Receivables	0.05^a	0.06^a
Deferred tax assets	0.91^a	0.21^a
Other investments	0.23^a	0.13^a
Total non-current assets	17.96^a	2.15^a
Corporate tax receivable	0.1^a	0^a
Inventories	0.06^a	0.06^a
Receivables	6.59^a	4.95^a
Marketable securities	11.24^a	13.27^a
Cash and cash equivalents	9.86^a	14.87^a
Total current assets	27.85^a	33.14^a
Total assets	45.81^a	35.29^a
Shareholders’ equity and liabilities	—	—
Share capital	0.07^a	0.07^a
Share premium	12.59^a	12.46^a
Other reserves	0.49^a	0.06^a
Retained earnings	23.55^a	19.02^a
Total shareholders’ equity	36.7^a	31.61^a
Lease liabilities	0.94^a	0.68^a
Contract liabilities	0.48^a	0.48^a
Deferred tax liabilities	2.36^a	0^a
Other payables	0.03^a	0.04^a
Total non-current liabilities	3.81^a	1.2^a
Corporate tax payable	1.71^a	0.05^a
Lease liabilities	0.09^a	0.09^a
Contract liabilities	0.02^a	0.03^a
Other payables	3.48^a	2.31^a
Total current liabilities	5.31^a	2.48^a
Total liabilities	9.11^a	3.68^a
Total shareholders’ equity and liabilities	45.81^a	35.29^a

Verified Sources Behind Genmab’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Genmab’s data sources below and access millions more through our Disclosure Search.

a. Genmab's Annual Report 2024

Trace every data point back to Genmab’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Genmab A/S

Financial Statements of Genmab

Verified Sources Behind Genmab’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Ascendis Pharma A/S

Coloplast A/S

H Lundbeck A/S

Ambu A/S

Demant A/S

Novo Nordisk A/S